May is #SkinCancer Awareness Month 📣

Check out our NEW podcast episode: Updates in #immunotherapy for #skincancer 🎧

With leading experts Omid Hamid MD Paolo A. Ascierto Professor Georgina Long AO & Karijn Suijkerbuijk

👉 vjoncology.com/podcast/update…

Join us for our Post-ASCO 2024 #GUCancer Highlights 📣

🌟 Chaired by Tom Powles

Featuring presentations & panel discussions on selected abstracts from #ASCO 2024 🔦

Agenda available soon 📝

REGISTER 👉 us06web.zoom.us/webinar/regist…

#ASCO 24

Glad to share our study about suboptimal ovarian suppression during adjuvant ET. Even if the landscape in this setting is changing, ET remains the cornerstone for these patients.
VJ Oncology vjoncology.com/video/dhjipjiz…

The role of primary tumor resection in metastatic #well -differentiated #GEPNET by Ashley Russo Timothy DiPeri, MD Joshua Tseng MD MBA Dr. Andrew Hendifar et al. Alexandra Gangi, MD

Median OS w/PTR:
PNET (136 vs. 61 mos, p = .003)
SBNET (NR vs. 79 mos, p<.001)

onlinelibrary.wiley.com/doi/10.1111/jn…

OncoAlert
Cancer at Cedars-Sinai

Dear Colleagues,
Inviting you to register to this Virtual webinar hosted by our collaborators at VJ Oncology on selected abstracts in #LungCancer 🫁from #ASCO24

Link to Register: us06web.zoom.us/webinar/regist…

Date: June 19, 2024 (5pm CEST)
Chaired by Sanjay Popat 🇬🇧

The OncoAlert🚨NEWSLETTER OUT
Covering May 17-23 , 2024

REGISTER at OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoale…

Discussing:
✅ICI’s 💉for POLE or POLD1 in met CRC
✅Advancements in mgt of Synchronous CRC Liver Mets
✅5yr outcome w/pembro💉 mono NSCLC🫁
✅SBRT☢️ in Lung

Join us for our Post-ASCO 2024 Highlights 📣

Featuring presentations & panel discussions on selected abstracts from #ASCO 2024 🔦

Agendas available soon 📝

REGISTER 👉 vjoncology.com/feature/post-a…

#ASCO 24 Sanjay Popat Tom Powles Sara Tolaney Lizzy Smyth

Dear Colleagues,
Inviting you to register to this Virtual webinar hosted by our collaborators at VJ Oncology on selected abstracts in #GICancer from #ASCO24

Link to Register: us06web.zoom.us/webinar/regist…

Date: June 24, 2024 (5pm CEST) Chaired by Lizzy Smyth 🇮🇪

Dear Colleagues,
Join our Collaborators at VJ Oncology for Great #BreastCancer coverage and News from #ESMOBreast24 🇩🇪

bit.ly/VJOncologyESMO…

Our Collaborators at VJ Oncology would like to remind all who followed #ESMOBreast24 that there is plenty of Expert-led updates on their Newsletter.
LINK:
bit.ly/VJOncologyNews…

Sara Tolaney Icro Meattini Hope Rugo Paolo Tarantino

Missed out on #ESMOBreast24 last week?

VJOncology.com has the key updates, brought to you by the experts themselves - ready to watch whenever you are! 👀

@‌myESMO #bcsm #breastcancer

Join us for our Post-ASCO 2024 #LungCancer Highlights 📣

🌟 Chaired by Professor Sanjay Popat

Featuring presentations & panel discussions on selected abstracts from #ASCO 2024 🔦

Agenda available soon 📝

REGISTER 👉 us06web.zoom.us/webinar/regist…

#ASCO 24

🎥Leonardo Provenzano, MD, from Istituto Tumori explores machine learning to predict early progression in HR+/HER2- advanced #breastcancer using data from the PALMARES-2 study:

➡️ow.ly/5art50RJWT0⬅️

ESMO - Eur. Oncology #ESMOBreast24

At #ESMOBreast24 I discussed with VJ Oncology the results of our work

➡️Low incidence (~3%) of lobular histology in a large cohort (n>4,600‼️) of young women with gBRCA mutations and early #breastcancer

OncoAlert Lobular Breast Cancer Alliance ESMO - Eur. Oncology Matteo Lambertini, MD PhD

vjoncology.com/video/rctr7-ej…

🎥Elisabetta Munzone of IEO discusses the Phase III PREcoopERA trial on giredestrant in premenopausal ER+/HER2- #breastcancer :

➡️ow.ly/rOye50RJWy9⬅️

ESMO - Eur. Oncology #ESMOBreast24

🚨 Don't miss the latest episode of our weekly podcast!

This week we're showcasing highlights from #ESMOBreast24

👂Listen here: tinyurl.com/2bbz5sbc

#BreastCancer #BCsm ESMO - Eur. Oncology OncoAlert

May is #SkinCancerAwarenessMonth 📣

According to The American Cancer Society an estimated 100,640 new #melanomas will be diagnosed in the USA in 2024 🇺🇸

Check out our skin cancer channel for the latest news and updates 👉 vjoncology.com/subject/skin-c…

📢We’re so excited! Only two weeks to go until #ASCO24 !

From May 31st we’ll be interviewing #Oncology experts – to discover the latest in cancer treatment innovations head to ➡️VJOncology.com⬅️

ASCO VJ Oncology

#ESMOBreast24 | We had the pleasure to speak to FIORITA POULAKAKI, who discusses QoL issues after axillary treatment in #breastcancer .

Watch out for her interview and our latest podcast episode on our congress highlights at VJOncology.com🎙️

ESMO - Eur. Oncology #bcsm @Oncoalert

Prof. Loibl presents f/u from GeparX looking at denosumab 🦴 with nab-paclitaxel

No significant improvement in iDFS with denosumab

For non-pCR patients, tx with weekly nab-paclitaxel seemed to be better (🔼10%)

#ESMOBreast2024
#bcsm
#ESMOAmbassadors